Alcohol withdrawal
Background
Clinical Features
- Reduction in alcohol use that has been heavy and prolonged
- At least 2 of the following
- Autonomic hyperactivity (e.g., diaphoresis, [[tachycardia|HR>100)
- Increased hand tremor
- Insomnia
- Nausea/vomiting
- Transient visual, tactile, or auditory hallucinations
- Psychomotor agitation
- Anxiety
- Grand mal seizures
Tremulousness
- Onset after last drink: 6-12h
Alcoholic Hallucinosis
- Onset after last drink: 12-24hr
- Visual hallucinations are most common
- Different from delirium tremens
- Resolves within 24-48 from last drink (before onset of DTs)
- No delirium
- Normal vital signs
Delirium tremens
- Onset after last drink: 48+hrs
- Decreased attention and awareness
- Disturbance in attention, awareness, memory, orientation, language, perception, visouspatial ability that fluctuates in severity
- No evidence of coma or other evolving neurocognitive disorders
Differential Diagnosis
Ethanol related disease processes
- Ethanol toxicity
- Alcohol use disorder
- Alcohol withdrawal
- Alcohol withdrawal seizures
- Delerium tremens
- Electrolyte/acid-base disorder
Sedative/hypnotic withdrawal
- Toxic alcohols
- Ethanol
- Ethylene glycol
- Methanol
- Isopropyl alcohol
- Benzodiazepines
- Flunitrazepam (Rohypnol)
- Gamma hydroxybutyrate (GHB)
- Barbiturates
- Opioids
- Chloral hydrate
Seizure
- Epileptic seizure
- First-time seizure
- Seizure with known seizure disorder
- Status epilepticus
- Temporal lobe epilepsy
- Non-compliance with anti-epileptic medications
- Non-epileptic seizure
- Meningitis
- Encephalitis
- Brain abscess
- Intracranial hemorrhage
- Alcohol withdrawal
- Benzodiazepine withdrawal
- Barbiturate withdrawal
- Baclofen withdrawal
- Metabolic abnormalities: hyponatremia, hypernatremia, hypocalcemia, hypomagnesemia, hypoglycemia, hyperglycemia, hepatic failure, uremia
- Eclampsia
- Neurocysticercosis
- Posterior reversible encephalopathy syndrome
- Impact seizure (head trauma)
- Acute hydrocephalus
- Arteriovenous malformation
- Seizure with VP shunt
- Toxic ingestion (amphetamines, anticholinergics, cocaine, INH, organophosphates, TCA, salicylates, lithium, phenothiazines, bupropion, camphor, clozapine, cyclosporine, fluoroquinolones, imipenem, lead, lidocaine, metronidazole, synthetic cannabinoids, theophylline, Starfruit)
- Psychogenic nonepileptic seizure (pseudoseizure)
- Intracranial mass
- Syncope
- Hyperventilation syndrome
- Migraine headache
- Movement disorders
- Narcolepsy/cataplexy
- Post-hypoxic myoclonus (Status myoclonicus)
Evaluation
- Consider workup for alternate etiologies if clinical presentation unclear
- Consider workup to evaluate any symptoms that led patient to stop drinking (e.g. did patient stop in setting of feeling unwell due to abdominal pain, pneumonia, etc.?)
CIWA score
Clinical Institute Withdrawal Assessment – Alcohol – revised (CIWA-Ar)
- Headache 0-7
- Orientation 0-4
- Tremor 0-7
- Sweating 0-7
- Anxiety 0-7
- Nausea (and Vomiting) 0-7
- Tactile Hallucinations 0-7
- Auditory Hallucinations 0-7
- Visual Hallucinations 0-7
- Agitation 0-7
Maximum Score = 67
- <8: Typically do not require medication
- 8-19: Medication
- ≥20: Medication and admission
Inpatient Management
Start aggressive Benodiazepine therapy at CIWA score of 8. Consider ICU admission with score >20
Benzodiazepine overview
Agents | Equivalent PO dose (mg) | Route | Onset of Action (min) | Half Life (hr) | Metabolism |
Chlordiazepoxide | 25 | PO, IV | 30 - 120 | 7-28 | CYP; active metabolites |
Diazepam | 5 | PO, IV, IM | 2 - 5 | 20-120 | CYP; active metabolites |
Lorazepam | 1 | PO, IM, IV | 15-20 | 8-19 | Glucuronidation |
Benzodiazepines
- Diazepam (Valium) 5-10 mg IV (depending on severity)
- May repeat q5-10 min for severe withdrawal (may increase dose by 10 mg every 5-10 min until desired effect achieved, max dose of 200 mg)
- Half-life 20-100 h (long acting)
- Lorazepam (Ativan) 1-4mg IV (depending on severity)
- May repeat q15-20 min for severe withdrawal (titrated to effect)
- Rarely causes hepatitis, as opposed to diazepam which may cause a cholestatic hepatitis[1]
- Half-life 10-20 h (medium acting)
Propofol
- If patient does not respond to high doses of benzodiazepines
- 0.3-1.25 mg/kg up to 4 mg/kg/hr (consider intubation), for up to 48 hours
α-2 agonists (Dexmedetomidine)
- Decrease severity of symptoms, but only supplemental to GABA-ergic first-lines
- Dexmedetomidine drip, start 0.2 mcg/kg/min, likely needing no more than 0.7 mcg/kg/min
Barbiturates (Phenobarbital)
- Used when refractory to benzodiazepines (consider after patient has received equivalent of 200 mg diazepam)
- Phenobarbital 130-260 mg IV q 15-20 minutes
- Can also be used as a first line load at 10 mg/kg prior to giving benzodiazepines to decrease benzodiazepine requirements and ICU admissions [2]
Ketamine
- May have some use in refractory cases
- Blocks the NMDA receptor which is excited an unregulated. [3]
Vitamin Prophylaxis for Chronic alcoholics
- At risk for thiamine deficiency, but no symptoms: thiamine 100mg PO q day
- Give multivitamin PO; patient at risk for other vitamin deficiencies
Banana bag
The majority of chronic alcoholics do NOT require a banana bag[4][5]
- Thiamine 100mg IV
- Folate 1mg IV (cheaper PO)
- Multivitamin 1 tab IV (cheaper PO)
- Magnesium sulfate 2mg IV
- Normal saline as needed for hydration
Special Situations
- The propylene glycol diluent in lorazepam, phenobarbital, and diazepam, may induce a hyperosmolar anion gap metabolic acidosis if given as a drip in high doses ≥ 48hrs.[6] Consider alternatives such as propofol or dexmedetomidine if patients need long term sedation for delirium tremens.
Outpatient Management
Don’t use phenytoin or fosphenytoin to treat seizures caused by drug toxicity or drug withdrawal.[7]
Chlordiazepoxide
Generally for outpatient treatment of mild cases and as a taper
- 25-50mg of chlordiazepoxide is equivalent to 10mg of diazepam
- 50mg of chlordiazepoxide every 8 hours for two days, then decrease to 25mg every 8 hours for another two days followed by 25mg PRN as needed.
Anticonvulsants
- Have less abuse potential but may not prevent seizures[8]
- Gabapentin 400mg PO TID[9]
- Some protocols call for higher dosing - 600 or 800mg x1
- Similar efficacy to lorazepam in decreasing craving and anxiety[10]
- Questionable efficacy in preventing alcohol withdrawal seizures
- Carbamazepine taper[11]
- May start when BAL < 150 mg/dL
- Varying evidence in support of whether agent truly reduces of alcohol withdrawal seizures and delirium tremens
- 800 mg per day be fixed or tapered over 5-9 days
Example outpatient lorazepam taper
- 2 mg tid x3 days
- 2 mg BID on day 4
- 2 mg once on day 5
Example outpatient gabapentin taper
- 400 mg TID x3 days
- 300 mg BID on day 4
- 300 mg once on day 5
Example outpatient carbamazepine taper
- 200 mg q6hr day 1
- 200 mg q8hr day 2
- 200 mg q12hr day 3
- 200 mg QD days 4 and 5
Disposition
Admit
- Multiple seizures
- DTs
- Decreased LOC
- Inability to control withdrawal after administrating 3-4 doses of benzo's
- Consider ICU admission with CIWA score >20
Discharge
- Two consecutive CIWA scores (two hours apart) <10 with resolution of tremor
- Consider discharge with 3 day course of benzodiazepines if patients are attempting to quit alcohol (controversial)
- Consider possible exclusions for outpatient treatment[12]:
- Substance use disorders except alcohol, nicotine, or cannabis
- Major Axis I psych disorder
- Medication history of benzodiazepines, beta-blockers, calcium-channel blockers, antipsychotics
- History of head injury, epilepsy, medical instability, ECG abnormality, grossly abnormal lab value
See Also
External Links
References
- National Institute of Diabetes and Digestive and Kidney Diseases. Lorazepam Drug Record. http://livertox.nih.gov/Lorazepam.htm
- Rosenson J, et al. Phenobarbital for acute alcohol withdrawal: a prospective randomized double-blind placebo-controlled study. J Emerg Med. 2013; 44(3):592-598.
- Wong, A et al. Evaluation of adjunctive ketamine to benzodiazepines for management of alcohol withdrawal syndrome. Ann Pharmacother. 2015 Jan;49(1):14-9. PMID: 25325907
- Krishel, S, et al. Intravenous Vitamins for Alcoholics in the Emergency Department: A Review. The Journal of Emergency Medicine. 1998; 16(3):419–424.
- Li, SF, et al. Vitamin deficiencies in acutely intoxicated patients in the ED. The American Journal of Emergency Medicine. 2008; 26(7):792–795.
- Arroliga AC, Shehab N, McCarthy K, Gonzales JP. Relationship of continuous infusion lorazepam to serum propylene glycol concentration in critically ill adults*. Critical Care Medicine. 2004;32(8):1709–1714. doi:10.1097/01.CCM.0000134831.40466.39.
- Choosing Wisely. American College of Medical Toxicology and The American Academy of Clinical Toxicology. http://www.choosingwisely.org/clinician-lists/acmt-and-aact-phenytoin-or-fosphenytoin-to-treat-seizures/
- Muncie HL et al. Outpatient Management of Alcohol Withdrawal Syndrome. Am Fam Physician. 2013 Nov 1;88(9):589-595.
- Leung JG, Hall-Flavin D, Nelson S, et al. The role of gabapentin in the management of alcohol withdrawal and dependence. Ann Pharmacother. 2015; 49(8):897-906.
- Myrick, H et al. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009 Sep;33(9):1582-8. PMID: 19485969
- Barrons R et al. The role of carbamazepine and oxcarbazepine in alcohol withdrawal syndrome. J Clin Pharm Ther. 2010 Apr;35(2):153-67.
- Myrick et al. A DOUBLE BLIND TRIAL OF GABAPENTIN VS. LORAZEPAM IN THE TREATMENT OF ALCOHOL WITHDRAWAL. Alcohol Clin Exp Res. 2009 Sep; 33(9): 1582–1588. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2769515/
This article is issued from
Wikem.
The text is licensed under Creative
Commons - Attribution - Sharealike.
Additional terms may apply for the media files.